Tomas Kvasnicka

Prof. Dr. Tomas Kvasnicka


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
INIvan Netuka
Ivan Netuka
TKTomas Kvasnicka
Tomas Kvasnicka
JKJan Kvasnička
Jan Kvasnička
IHIngrid Hrachovinová
Ingrid Hrachovinová
PIPeter Ivák
Peter Ivák
MMMandeep Mehra
Mandeep Mehra

1 February 2005 in Psychiatry Research
Verified
Journal Article
Closed access
JVJan Vevera
Jan Vevera
ZFZdeněk Fišar
Zdeněk Fišar
TKTomas Kvasnicka
Tomas Kvasnicka
HZHanuš Zdeněk
Hanuš Zdeněk
LSLucie Stárková
Lucie Stárková
HPHana Papežová
Hana Papežová

6 April 2016 in BMC Surgery
Verified
Journal Article
Open access
PDF file
JUJan Ulrych
Jan Ulrych
TKTomas Kvasnicka
Tomas Kvasnicka
VFVladimir Fryba
Vladimir Fryba
MKMartin Komarc
Martin Komarc
IMIvana Malikova
Ivana Malikova
ZKZdeněk Krška
Zdeněk Krška
Surgery for benign disease is associated with a low-risk of developing venous thromboembolism (VTE). Despite a relatively low incidence of postoperative VTE in patients after elective cholecystectomy and abdominal hernia repair there are data proving hypercoagulability in the early postoperative period. We focused on assessment of the systemic inflammatory response and coagulation status in these surgical patients after hospital discharge. Prospectively, patients who underwent surgery for benign disease were included. Two hundred sixteen patients were enrolled - 90 patients in laparoscopic cholecystectomy (LC) group and 126 patients in hernia surgery (HS) group. Risk assessment of VTE according to the Caprini risk assessment model was performed in all patients. Prevalence of VTE in postoperative period was observed. Markers of systemic inflammatory response (IL-6, CRP, α-1-acid glycoprotein, transferrin) and coagulation markers (PLT, fibrinogen, prothrombin fragment F1 + 2 and D-dimer) were measured before surgery, on 7–10th postoperative day and on 28–30th postoperative day. Clinically apparent deep vein thrombosis was diagnosed in only one patient - 0.46 %. Statistically significant elevation of inflammatory markers IL-6, CRP and α-1-acid glycoprotein (p < 0.001; all) were proved in both groups of patients on 7–10th postoperative day. Statistically significant elevation of coagulation markers PLT, fibrinogen, prothrombin fragment F1 + 2 and D-dimer (p < 0.001; all) were proved in LC and HS groups on 7–10th postoperative day. No statistical difference was observed in IL-6, CRP and α-1-acid glycoprotein levels a month after surgery as compared with preoperative levels within each group. Statistically significant elevation of fibrinogen and prothrombin fragment F1 + 2 levels (p < 0.001; both) persisted on 28–30th postoperative day in both groups. Persisted elevation of D-dimer levels was proved only in HS group (p < 0.001), not in LC group (p = 0.138), a month after surgery. Activated systemic inflammatory response and hypercoagulable condition were verified in patients after laparoscopic cholecystectomy and hernia surgery after their hospital discharge. Hypercoagulability persisted even a month after surgery. Nevertheless, we observed very low prevalence of clinically apparent VTE in patients with in-hospital postoperative VTE prophylaxis. Trials of the Czech Ministry of Health No. RVO-VFN64165 and NT 13251-4 .

19 May 2000 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
JKJan Kvasnička
Jan Kvasnička
JMJosef Marek
Josef Marek
TKTomas Kvasnicka
Tomas Kvasnicka
VWVladimír Weiss
Vladimír Weiss
MMMarkéta Marková
Markéta Marková
AUAnna Umlaufová
Anna Umlaufová

8 July 1996 in APMIS
Verified
Journal Article
Closed access
PDF file
WWWenliang Wang
Wenliang Wang
HJHenry Johansson
Henry Johansson
TKTomas Kvasnicka
Tomas Kvasnicka
LFLars‐Ove Farnebo
Lars‐Ove Farnebo
LGLars Grimelius
Lars Grimelius

25 September 2014 in Perfusion
Verified
Journal Article
Closed access
FMF Mlejnsky
F Mlejnsky
AKA A Klein
A A Klein
JLJarosla Lindner
Jarosla Lindner
PMP Maruna
P Maruna
JKJ Kvasnicka
J Kvasnicka
JKJ Kunstyr
J Kunstyr
Objectives: There is some controversy as to whether there is a benefit from the use of a centrifugal pump compared with a roller pump during cardiopulmonary bypass to facilitate cardiac surgery. We compared the two pumps, with the primary aim of determining any difference in the effects on inflammation after pulmonary endarterectomy surgery which required prolonged cardiopulmonary bypass and deep hypothermic circulatory arrest. Methods: Between September 2010 and July 2013, 58 elective patients undergoing pulmonary endarterectomy were included in this prospective, randomised, controlled study; 30 patients were randomly allocated to the control group, which used a roller pump, and 28 patients to the treatment group, which used a centrifugal pump. Interleukin-6, procalcitonin, C-reactive protein, thromboelastographic parameters, P-selectin, international normalised ratio, activated prothrombin time, free haemoglobin, haematocrit, red blood cell count, white blood cell count, platelet count and protein S100β were recorded during and after the procedure. We also recorded the length of intensive care unit stay, blood loss and transfusion, neurological outcomes and respiratory and renal failure. Results: There was a significant difference in the primary outcome measure: Interleukin-6 was significantly higher in the roller pump group (587±38 ng·l-1 vs. 327±37 ng·l-1; p<0.001) 24 hours after surgery, which we interpreted as an increased inflammatory response. This was confirmed by a significant rise in the procalcitonin level in the roller pump group 48 hours following surgery (0.79 (0.08-25.25) ng·ml-1 vs. 0.36 (0.02-5.83) ng·ml-1; p<0.05). There were, however, no significant differences in clinical outcome data. Conclusions: We have shown that the use of a centrifugal pump during prolonged cardiopulmonary bypass and deep hypothermic circulatory arrest is associated with a reduced inflammatory response compared to the standard roller pump. Larger multi-centre trials in this area of practice are required.